Reason for request
Inclusion on the list of medicines refundable by National Health Insurance and approved for hospital use.
Clinical Benefit
| Low |
The actual benefit of BRONCHITOL is low. |
Clinical Added Value
| no clinical added value |
BRONCHITOL does not offer any improvement in actual benefit (IAB V) in the management of adult patients aged 18 and over with cystic fibrosis. |
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
nAnuCHWM3XVdkfLK
Listen
